Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis

Abstract

The preoperative plasma suPAR level independently predicted survival of patients with colorectal cancer. Further studies of plasma suPAR in patients with cancer are needed to evaluate the utility of plasma suPAR measurements and cut points in identifying high-risk patients among those with early stage disease.